Pricing Log in Create free account

Fortrea Holdings Inc. (FTRE) vs Viridian Therapeutics, Inc. (VRDN)

Fortrea Holdings Inc. and Viridian Therapeutics, Inc. are both Biotechnology companies. Fortrea Holdings Inc. and Viridian Therapeutics, Inc. are of similar size ($2.2B and $2.2B). Viridian Therapeutics, Inc. grew revenue faster over the last twelve months: 23,220.3% against −2.09%. Fortrea Holdings Inc. has the higher net margin (−3.18% vs −544.1%) and the lower return on invested capital (−0.48% vs 0.00%). Across the 18 metrics below, Fortrea Holdings Inc. leads on 9 and Viridian Therapeutics, Inc. on 9.

Valuation

Metric FTRE VRDN Biotechnology median
P/E n/m n/m 8.50
P/S 0.80 28.86 9.71
P/B 4.07 3.64 2.13
Price to free cash flow 10.77 n/m 20.82
EV/EBITDA 44.71 n/m 0.64
EV/Sales 1.13 18.59 9.21
Earnings yield (4.05%) (17.71%) (33.15%)
Free cash flow yield 9.29% (16.32%) (25.50%)

Profitability

Metric FTRE VRDN Biotechnology median
Gross margin 19.30% 100.00% 65.16%
Operating margin (0.40%) (569.68%) 0.00%
Net margin (3.18%) (544.06%) 0.00%
Free cash flow margin 7.40% (471.04%) 0.00%
Return on equity (15.30%) (86.93%) (56.36%)
Return on assets (3.07%) (46.08%) (48.04%)
Return on invested capital (0.48%) 0.00% 0.00%

Growth

Metric FTRE VRDN Biotechnology median
Revenue growth (TTM) (2.09%) 23,220.33% 6.02%
EPS growth (last fiscal year) (194.55%) (8.14%) 30.26%
Revenue growth, 5-year CAGR 1.09% 132.18% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FTRE VRDN Biotechnology median
Debt to equity 2.01 0.37 0.00
Current ratio 0.96 16.95 4.72
Net debt to EBITDA 266.13 2.23 0.96

Dividend

Metric FTRE VRDN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FTRE VRDN Biotechnology median
Market cap 2.16b 2.22b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack